90841-64-8 Usage
Uses
Used in Pharmaceutical Research:
1-(4-bromo-2,5-dimethoxyphenyl)ethanone is used as an intermediate in pharmaceutical research for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(4-bromo-2,5-dimethoxyphenyl)ethanone is used as a building block for the production of other organic compounds. Its versatile structure makes it a valuable precursor in the synthesis of specialty chemicals with specific properties and applications.
Used in Drug Development:
1-(4-bromo-2,5-dimethoxyphenyl)ethanone has potential applications in the development of new drugs. Its chemical properties and structure can be utilized to create novel pharmaceuticals with improved efficacy, safety, and selectivity for various therapeutic targets.
Used in Chemical Industry:
In the chemical industry, 1-(4-bromo-2,5-dimethoxyphenyl)ethanone can be employed as a raw material or intermediate in the synthesis of specialty chemicals. Its unique structure and reactivity make it suitable for the production of various chemical products with specific applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 90841-64-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,8,4 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 90841-64:
(7*9)+(6*0)+(5*8)+(4*4)+(3*1)+(2*6)+(1*4)=138
138 % 10 = 8
So 90841-64-8 is a valid CAS Registry Number.
90841-64-8Relevant academic research and scientific papers
SYNTHESIS OF THE C-GLYCOSIDE FRAGMENT OF NOGALAMYCIN AND SOME NOGALAMYCIN PRECURSORS
Bates, Mark A.,Sammes, Peter G.,Thomson, Gordon A.
, p. 3037 - 3046 (2007/10/02)
A short, stereoselective method for generation of the fused C-glycoside unit of the anticancer agent nogalamycin is described; in particular, synthesis of the D,E,F ring system.The method utilises a total synthesis of the glycosidic unit from an aryl fury